copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary . . . Objective To investigate whether Lp(a) is associated with cardiovascular risk independent of high-sensitivity C-reactive protein (hs-CRP) in both primary and secondary prevention populations Design, Setting, and Participants This cohort study uses data from 3 distinct cohorts, 1 population-based cohort and 2 randomized clinical trials
Association of Lipoprotein(a) With Major Adverse Cardiovascular Events . . . High-sensitivity C-reactive protein (hs-CRP) is a widely recognized biomarker of systemic inflammation, often used in clinical settings to assess inflammatory status as well as inflammation-related ASCVD risk 7 Multiple recent studies have evaluated the association of Lp(a) with the risk of major adverse cardiovascular events (MACE) in the
The association between C-reactive protein and coronary artery . . . The American Heart Association has recommended the inclusion of high-sensitivity C-reactive protein (hs-CRP) in the overall assessment of cardiovascular risk Over time, this concept has evolved, and in 2010, the American College of Cardiology Foundation advised that evaluating CRP levels is a sensible approach for individuals at intermediate
C-Reactive Protein Levels and Risk of Cardiovascular Diseases: A Two . . . Elevated C-reactive protein (CRP) levels are an indicator of inflammation, a major risk factor for cardiovascular disease (CVD) However, this potential association in observational studies remains inconclusive We performed a two-sample bidirectional Mendelian randomization (MR) study using publicly available GWAS summary statistics to evaluate the relationship between CRP and CVD
Inflammation, infection, and cardiovascular risk - The Lancet Elevated high-sensitivity C-reactive protein (CRP) concentration is considered a risk enhancer in non-diabetic individuals at intermediate risk of atherosclerotic cardiovascular disease, and favours initiating moderate-intensity statin as primary prevention 1 As stated in the Article by Paul M Ridker and colleagues, the residual inflammatory risk assessed by high-sensitivity CRP on
Elevated high-sensitivity C-reactive protein and the risk for . . . High sensitivity C-reactive protein (hs-CRP) is a biomarker used for risk prediction for cardiovascular disease by assessing low concentration of inflammation This study aims to assess the event-free time for the composite outcome between patients of different hs-CRP risk groups and the possible predictive value of hs-CRP for event occurrence
Synergistic effect of lipoprotein(a) and high-sensitivity C-reactive . . . Citation: Wang Z, Tang J, Shi Q, Fang L, Liu N and Zhang J (2024) Synergistic effect of lipoprotein(a) and high-sensitivity C-reactive protein on the risk of all-cause and cardiovascular death in patients with acute myocardial infarction: a large prospective cohort study Front Endocrinol 15:1392859 doi: 10 3389 fendo 2024 1392859
C-Reactive Protein and Risk of Cardiovascular Events and Mortality in . . . Patients with established cardiovascular disease (CVD) are at great risk of recurrent cardiovascular events, despite the routine use of lipid-lowering, blood pressure-lowering, and antithrombotic therapy 1 Besides traditional risk factors, chronic low-grade inflammation has emerged as a driving force of atherosclerotic disease 2 High-sensitivity C-reactive protein (CRP) is a well-established
C-reactive protein: A golden marker for inflammation and coronary . . . REVIEW ABSTRACT C Numerous studies have shown that elevated levels of C-reactive protein (CRP) are associated with increased cardiovascular risk We advocate greater use of CRP measurements in clinical practice to identify patients at high risk in a variety of situations KEY POINTS The development of an atherosclerotic plaque involves a
High-sensitivity C-reactive protein as a biomarker of cardiovascular . . . Background: Development of high sensitivity CRP (Hs-CRP) assays has improved the role of this acute phase reactant in predicting the first cardiovascular events Hs-CRP levels partially reflect the extent of myocardial necrosis and can be used to predict in hospital and long-term outcome in patients with acute myocardial infarction Aims and Objectives: The objectives of the study are to study